NCT06617923 2025-10-27Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Recruiting18 enrolled
NCT00526617 2017-11-21A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer PatientsAbbViePhase 1 Completed41 enrolled